Sterling Capital Management’s Vaxcyte PCVX Stock Holding History

Sterling Capital Management’s Portfolio PCVX Stock Details PCVX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$68.2K	Sell	1,174 -2,965	-72%	-$161K	﹤0.01%	1501
2026 Q1	$241K	Sell	4,139 -2,475	-37%	-$134K	﹤0.01%	1099
2025 Q4	$305K	Sell	6,614 -1,314	-17%	-$58.8K	0.01%	1182
2025 Q3	$286K	Buy	7,928 +4,532	+133%	+$150K	﹤0.01%	1210
2025 Q2	$110K	Buy	3,396 +3,266	+2,512%	+$107K	﹤0.01%	1340
2025 Q1	$4.91K	Buy	130 +4	+3%	+$320	﹤0.01%	2179
2024 Q4	$10.3K	Buy	126 +4	+3%	+$397	﹤0.01%	2146
2024 Q3	$13.9K	Buy	+122	New	+$11K	﹤0.01%	1505

Other funds holding PCVX

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Jupiter Topco New York $245B AUM

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

Sterling Capital Management's PCVX Position: Q2 2026 in Review

Sterling Capital Management reduced its Vaxcyte (PCVX) stake by 72% in Q2 2026, selling an estimated $161K and leaving 1,174 shares worth $68.2K. The position accounts for ﹤0.01% of the portfolio, ranked #1501.

Sterling Capital Management first reported a position in PCVX in Q3 2024 and has held it in 8 quarters since. The position peaked at $305K in Q4 2025. 332 funds tracked by Wall St. Rank hold PCVX as of Q2 2026.

Sterling Capital Management held 1,174 shares of Vaxcyte worth $68.2K as of Q2 2026.
Sterling Capital Management sold 2,965 Vaxcyte shares in Q2 2026, an estimated $161K.
Vaxcyte made up ﹤0.01% of Sterling Capital Management's portfolio in Q2 2026, its #1501 holding.
Sterling Capital Management first reported a position in Vaxcyte in Q3 2024 and has held it in 8 quarters since.
Sterling Capital Management's Vaxcyte position peaked at $305K in Q4 2025.
332 funds tracked by Wall St. Rank held Vaxcyte as of Q2 2026.

Based on Sterling Capital Management's 13F filing for Q2 2026, filed 28 Jul 2026.